Emmaus Life Sciences' Unattributed - II Round

Emmaus Life Sciences raised a round of funding on January 26, 2016. Investors include Korea Bio Medical Science Institute.

Emmaus Life Sciences is a biopharmaceutical company engaged in the discovery, development and commercialization of innovative treatments and therapies primarily for rare and orphan disease. The compan…

Articles about Emmaus Life Sciences' Unattributed - II Round: